Vladimir Trkulja

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 16

Top Topics

Antiplatelet Therapy

Coronavirus Disease

Prognostic Factors

Ejection Fraction

Top Venues

European journal of clinical pharmacology

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Lana Ganoci, Jozefina Palić, Vladimir Trkulja, Katarina Starčević, Livija Šimičević, Nada Božina, Martina Lovrić-Benčić, Zdravka Poljaković, Tamara Božina
Is CYP2C Haplotype Relevant for Efficacy and Bleeding Risk in Clopidogrel-Treated Patients? Genes 15 (5) (2024)
Lana Ganoci, Jozefina Palić, Vladimir Trkulja, Katarina Starčević, Livija Šimičević, Nada Božina, Martina Lovrić-Benčić, Zdravka Poljaković, Tamara Božina
Is CYP2C Haplotype Relevant for Efficacy and Bleeding Risk in Clopidogrel-Treated Patients? Genes 15 (5) (2024)
Lana Ganoci, Jozefina Palić, Vladimir Trkulja, Katarina Starčević, Livija Šimičević, Nada Božina, Martina Lovrić-Benčić, Zdravka Poljaković, Tamara Božina
Is CYP2C Haplotype Relevant for Efficacy and Bleeding Risk in Clopidogrel-Treated Patients? Genes 15 (5) (2024)
Lana Ganoci, Jozefina Palić, Vladimir Trkulja, Katarina Starčević, Livija Šimičević, Nada Božina, Martina Lovrić-Benčić, Zdravka Poljaković, Tamara Božina
Is CYP2C Haplotype Relevant for Efficacy and Bleeding Risk in Clopidogrel-Treated Patients? Genes 15 (5) (2024)
Nada Božina, Ivana Šušak Sporiš, Iva Klarica Domjanović, Lana Ganoci, Livija Šimičević, Mila Lovrić, Zrinka Čolak Romić, Željka Petelin Gadže, Vladimir Trkulja
Bearing variant alleles at uridine glucuronosyltransferase polymorphisms UGT2B7 -161C > T (rs7668258) or UGT1A4*3 c.142 T > G (rs2011425) has no relevant consequences for lamotrigine troughs in adults with epilepsy. European journal of clinical pharmacology (2023)
Ivana Šušak Sporiš, Nada Božina, Iva Klarica Domjanović, Davor Sporiš, Silvio Bašić, Ivana Bašić, Mila Lovrić, Lana Ganoci, Vladimir Trkulja
Breast cancer resistance protein polymorphism ABCG2 c.421C>A (rs2231142) moderates the effect of valproate on lamotrigine trough concentrations in adults with epilepsy. Fundamental & clinical pharmacology (2023)
Vladimir Trkulja, Ivan Kodvanj
Outpatients prescribed with fluvoxamine around the time of COVID-19 diagnosis are not at a reduced risk of subsequent hospitalization and death compared to their non-prescribed peers: population-based matched cohort study. European journal of clinical pharmacology (2023)
Vladimir Trkulja
Fluvoxamine for COVID-19 ICU patients? British journal of clinical pharmacology 88 (5) (2022)
Vladimir Trkulja
Tocilizumab for reduction of mortality in severe COVID-19 patients: How should we GRADE it? British journal of clinical pharmacology 88 (7) (2022)
Ivan Kodvanj, Jan Homolak, Davor Virag, Vladimir Trkulja
Publishing of COVID-19 preprints in peer-reviewed journals, preprinting trends, public discussion and quality issues. Scientometrics 127 (3) (2022)
A Ana Borić-Bilušić, Nada Božina, Zdenka Lalić, Mila Lovrić, Sandra Nađ-Škegro, Luka Penezić, Karmela Barišić, Vladimir Trkulja
Loss of Function ABCG2 c.421C>A (rs2231142) Polymorphism Increases Steady-State Exposure to Mycophenolic Acid in Stable Renal Transplant Recipients: An Exploratory Matched Cohort Study. Advances in therapy (2022)
Vladimir Trkulja
Fluvoxamine for COVID-19 outpatients: For the time being, we might prefer to curb our optimism. British journal of clinical pharmacology 88 (10) (2022)
Ivan Kodvanj, Jan Homolak, Vladimir Trkulja
People exposed to proton-pump inhibitors shortly preceding COVID-19 diagnosis are not at an increased risk of subsequent hospitalizations and mortality: A nationwide matched cohort study. British journal of clinical pharmacology (2022)
Iveta Merćep, Ivana Radman, Vladimir Trkulja, Tamara Božina, Livija Šimičević, Ema Budimir, Lana Ganoci, Nada Božina
Loss of function polymorphisms in SLCO1B1 (c.521T>C, rs4149056) and ABCG2 (c.421C>A, rs2231142) genes are associated with adverse events of rosuvastatin: a case-control study. European journal of clinical pharmacology (2021)
Vladimir Trkulja
Remdesivir for COVID-19 pneumonia: still undecided, but it might all be about adequate timing. European journal of clinical pharmacology 77 (6) (2021)
Vladimir Trkulja, Ivan Kodvanj, Jan Homolak
Immunoglobulin G glycome and severity of COVID-19: more likely a quantification of bias than a true association. A comment on Petrović et al., "Composition of the immunoglobulin G glycome associates with the severity of COVID-19". Glycobiology 31 (7) (2021)